Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group

Eur J Cancer Clin Oncol. 1989 Apr;25(4):751-2. doi: 10.1016/0277-5379(89)90214-9.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Daunorubicin / analogs & derivatives*
  • Drug Administration Schedule
  • Drug Evaluation
  • Female
  • Humans
  • Infusions, Intravenous
  • Menogaril
  • Middle Aged
  • Nogalamycin / administration & dosage*
  • Nogalamycin / adverse effects
  • Nogalamycin / analogs & derivatives
  • Nogalamycin / therapeutic use
  • Ovarian Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Menogaril
  • Nogalamycin
  • Daunorubicin